Retraction “Advances in drug therapy for mitochondrial diseases”
The article entitled “Advances in drug therapy for mitochondrial diseases”, published in the Issue 1, Vol. 8 of Annals of Translational Medicine (1) is being retracted on the ground of plagiarism of the article titled “Therapies of mitochondrial diseases and current clinical trials” published in the Issue 3, Vol. 122 of Molecular Genetics and Metabolism (2). The editors and publisher have confirmed the retraction of this paper at the request of the authors and guest editor of the focused issue “Neurological Diseases”. All authors apologize for the misconduct due to the scientific negligence.
Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
References
- Zhang L, Zhang Z, Khan A, et al. Advances in drug therapy for mitochondrial diseases. Ann Transl Med 2020;8:17. [Crossref] [PubMed]
- El-Hattab AW, Zarante AM, Almannai M, et al. Therapies for mitochondrial diseases and current clinical trials. Mol Genet Metab 2017;122:1-9. [Crossref] [PubMed]
